Single-Institute Review of HER-2/Neu-Positive Invasive Lobular Breast Carcinoma in an Arab Population

由 Osmani, Asif Husain, Tulbah, Asma M., Alsayed, Adher, AlShanqeeti, Ali, Al-Twegieri, Taher, Ajarim, Dahish S., Suleman, Kausar
發表在 Am J Case Rep (2021)

Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience

由 Alshabanah Mohamed, Al Malik Osama, Tulbah Asma, Alsayed Adher, Al-Zahrani Ali, Ajarim Dahish, Dermime Said, Elkum Naser, Ezzat Adnan, Al-Tweigeri Taher
出版 2007-12-01

Being 40 or younger is an independent risk factor for relapse in operable breast cancer patients: The Saudi Arabia experience

由 Elkum, Naser, Dermime, Said, Ajarim, Dahish, Al-Zahrani, Ali, Alsayed, Adher, Tulbah, Asma, Al Malik, Osama, Alshabanah, Mohamed, Ezzat, Adnan, Al-Tweigeri, Taher
出版 2007

Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs

由 Suleman, Kausar, Mushtaq, Ali Hassan, Haque, Emaan, Badran, Ahmed Ali, Ajarim, Dahish, Elashwah, Ahmed Mohammed, Gad, Ahmed Mostafa, Abdelsamad, Amgad Shaheen, Omar, Ayman, Khan, Khurshid Ahmed, Al-Tweigeri, Taher, Elshentenawy, Ayman, Alsayed, Adher
發表在 Breast Care (Basel) (2021)